Gilead Sciences Ltd

Large enterpriseUK · LondonCompany No. 02543818

Gilead Sciences Ltd is a UK limited company, based in London, incorporated in 1990. Has won 79 UK public-sector contracts worth £622.9m across 14 buyers, primarily NHS England.

⇄ Compare peers ⇩ Export ↗ Share

Active contracts

no new awards in 30d

Contracted (12m)

£161.5m

▲ 226% vs prior 12m

Public buyers

stable this month

Top buyer share

75%

NHS England

Buyer concentration

Each block sized by share of total award value. A dominant block signals dependency on one buyer.

Severe concentration. Top buyer alone = 75% of revenue.

NHS England

£469.1m

75%

Department of Health and Social Care (DHSC)

£134.7m

22%

NHSE&I

£15.3m

Southern Health and Social Care Trust

£3.0m

The Clatterbridge Cancer Centre NHS Foundation Trust

£727k

Contracts won · 79 total · 41 active · 34 expired

Every contract award published under the Procurement Act.

Sort

Title	Buyer	Award type	Value	Awarded	Status
NHS England procurement for the supply of Pan-genotypic Direct Acting Antiviral (DAA) Hepatitis C treatments and the provision of Hepatitis C elimination initiatives	NHS England	Shared contract	£160.0m lot total · 2 suppliers	25 Feb 2026	pending
NHS Framework for the supply of Licensed Antiretroviral Therapy (ART) 1 Nov 2024	NHS England	Shared contract	£48.2m lot total · 13 suppliers	28 Oct 2024	active
NHS Framework Agreement - Hepatitis C Medicines	NHS England	Shared contract	£45.0m lot total · 4 suppliers	16 Apr 2018	expired
Supply of Remdesivir	Department of Health and Social Care (DHSC)	Framework call off	£21.5m ceiling · ~£21.5m share	15 Jan 2021	expired
Contract for the Supply of Remdesivir	Department of Health and Social Care (DHSC)	Framework call off	£21.5m ceiling · ~£21.5m share	13 Oct 2020	expired
Supply of Remdesivir	Department of Health and Social Care (DHSC)	Framework call off	£21.3m ceiling · ~£21.3m share	05 Nov 2020	expired
NHS Framework Agreement for Branded Medicines - National	NHS England	Shared contract	£18.5m lot total · 73 suppliers	01 May 2019	expired
NHS Framework Agreement - North of England - Tranche B	NHS England	Framework call off	£17.4m ceiling · ~£579k share (÷30)	13 Feb 2018	expired
NHS Framework Agreement - North of England - Tranche B	NHS England	Framework call off	£17.4m ceiling · ~£579k share (÷30)	08 Jan 2018	expired
Supply of Remdesivir	Department of Health and Social Care (DHSC)	Direct contract	£17.3m	31 Mar 2022	expired
NHS England Framework Agreement: South of England (Tranche B)	NHS England	Framework call off	£15.7m ceiling · ~£490k share (÷32)	14 Sept 2018	expired
NHS Midlands and East Branded Medicines - Tranche A	NHS England	Shared contract	£15.5m lot total · 27 suppliers	15 Jan 2020	expired
National Procurement for HIV and Preventative Treatments	NHSE&I	Shared contract	£15.3m lot total · 15 suppliers	01 Feb 2022	expired
NHS Midland & East Branded Medicines, Tranche B & Annual Tranche	NHS England	Shared contract	£13.7m lot total · 35 suppliers	13 Feb 2023	expired
NHS Framework Agreement, Branded Medicines for London and South of England	NHS England	Framework call off	£13.3m ceiling · ~£317k share (÷42)	19 Aug 2021	expired

Showing 1–15 of 79

Gilead Sciences Ltd

Buyer concentration

Contracts won · 79 total · 41 active · 34 expired

Top buyers · by total award value

Award value — last 8 quarters

Category mix — CPV divisions

Geographic spread

Modifications received · scope growth on existing wins

Compliance scorecard

Financial health

Company information

Corporate structure

Companies House data

Peer suppliers

News mentions

Compliance scorecard

Financial health

Company information

Corporate structure

Gilead Sciences Ltd

Companies House data

Why Capita's public-sector share keeps slipping — and who's eating it

The 12 frameworks Capita bid on last year (and lost 8)

Is BPO concentration back? A supplier-risk deep-dive